RE:RE:Ryplazim is worth more than the stated $8 Billion market When all is said and done, the plasminogen (Ryplazim) worldwide market will be closer to $15 Billion then to the touted $8 Billion.
Plasminogen is a part of all human healing, and there are many more indications than PL has so far indicated. But then anyone who reads medical and scientific literature would already know those facts in advance. Too bad you don’t read.
No, you GunnerG just complain and whine in life, you’re a typical underachiever trying to find fault in others to make yourself feel better about your situation. Your words betray you. Your projection on others are transparent. FREE ADVICE: read more and talk less.
GunnerG wrote: Here is one where PL said $8 billion and what did you do; bumped it to $15 billion. Don't blame PL, you have taken his dates and his market comments and changed them for your pumping needs. Fluff pumpers, oye.
Make up your mind Bio, is it an $8 billion market or your Dec 2017 prediction of $15 billion.
Fluff pumper, please stop guessing or at least stick to one number LOL.
Bragging to shorts you were correct, "I TOLD YOU SO". Dec 18 sp $1.34 price now, .80. I think the shorts hold the rights to "I TOLD YOU SO".
As I said, your wrong on your dates and your wrong on your market numbers. Biofinder wrote: I love to say it, “I TOLD YOU SO” to all you dumb a$$ shorters (GunnerGFUD) who doubted my previous postings.
Like I previously posted, Prometic’s plasminogen franchise is worth closer to $15 Billion dollars USD when all the indications for Ryplazim/plasminogen is disclosed by PL. There are many many more Ryplazim targets to be disclosed in the very near future.
Combined with Ryplazim’s safety profile, Ryplazim being a naturally occurring human protein produced by the liver, and the upcoming FDA approval for Plasminogen Deficiency, any new Ryplazim trials should move right into phase II/III.